AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study 27716172 — intervention group
Group type: COMPARATOR
Intervention: Vehicle
Number of subjects: 435
Study 27716172 — intervention group
Group type: EXPERIMENTAL
Intervention: Overall
Number of subjects: 435
Study 24595778 — intervention group
Group type: EXPERIMENTAL
Intervention: Low-poverty voucher group (n=1430)
Number of subjects: 3689
Study 24595778 — intervention group
Group type: EXPERIMENTAL
Intervention: Traditional voucher group (n=1081)
Number of subjects: 3689
Study 24595778 — intervention group
Group type: COMPARATOR
Intervention: Control group (n=1178)
Number of subjects: 3689
Study 23760519 — intervention group
Group type: EXPERIMENTAL
Intervention: Ultrasonography-guided bilateral rectus sheath block (BRSB)
Number of subjects: 52
Study 23760519 — intervention group
Group type: COMPARATOR
Intervention: Local anesthetic infiltration (LAI)
Number of subjects: 52
Study 20020207 — intervention group
Group type: EXPERIMENTAL
Intervention: Sevelamer hydrochloride
Number of subjects: 22
Study 20020207 — intervention group
Group type: COMPARATOR
Intervention: Calcium acetate
Number of subjects: 22
Study 17716819 — intervention group
Group type: EXPERIMENTAL
Intervention: Graded in vivo exposure
Number of subjects: 44
Study 17716819 — intervention group
Group type: COMPARATOR
Intervention: Graded activity
Number of subjects: 44
Study 17716819 — intervention group
Group type: COMPARATOR
Intervention: Wait-list control
Number of subjects: 44
Study 17148518 — intervention group
Group type: EXPERIMENTAL
Intervention: Constraint‐Induced Movement Therapy plus donepezil (CIMT‐6 study)
Number of subjects: 39
Study 17148518 — intervention group
Group type: COMPARATOR
Intervention: Constraint‐Induced Movement Therapy plus repetitive transcranial magnetic stimulation (CIMT‐1 study)
Number of subjects: 39
Study 14569738 — intervention group
Group type: COMPARATOR
Intervention: 400 mg daily of vaginally administrated Cyclogest (progesterone) alone
Number of subjects: 118
Study 14569738 — intervention group
Group type: EXPERIMENTAL
Intervention: 400 mg daily of vaginally administrated Cyclogest (progesterone) in combination with 2 mg daily of oral Oestradiol Valerate (E2V)
Number of subjects: 118
Study 14569738 — intervention group
Group type: EXPERIMENTAL
Intervention: 400 mg daily of vaginally administrated Cyclogest (progesterone) with E2V
Number of subjects: 118
Study 12175626 — intervention group
Group type: EXPERIMENTAL
Intervention: Nadolol
Number of subjects: 52
Study 12175626 — intervention group
Group type: COMPARATOR
Intervention: Isosorbide mononitrate (IsMn)
Number of subjects: 52
Study 10355235 — intervention group
Group type: EXPERIMENTAL
Intervention: Lexical decision to the prime
Number of subjects: 0
Study 10355235 — intervention group
Group type: COMPARATOR
Intervention: Reading the prime silently
Number of subjects: 0
Study 10355235 — intervention group
Group type: EXPERIMENTAL
Intervention: Naming the prime
Number of subjects: 0
Study 10355235 — intervention group
Group type: EXPERIMENTAL
Intervention: Short (120-msec) prime-target stimulus onset asynchrony
Number of subjects: 0
Study 10355235 — intervention group
Group type: EXPERIMENTAL
Intervention: Associative prime processing
Number of subjects: 0
Study 7717558 — intervention group
Group type: EXPERIMENTAL
Intervention: Spinal anesthesia with lidocaine
Number of subjects: 10
Study 7717558 — intervention group
Group type: COMPARATOR
Intervention: Epidural anesthesia with lidocaine
Number of subjects: 10
Study 2285437 — intervention group
Group type: EXPERIMENTAL
Intervention: Early discharge (12 to 24 hours)
Number of subjects: 131
Study 2285437 — intervention group
Group type: EXPERIMENTAL
Intervention: Early discharge (25 to 48 hours)
Number of subjects: 131
Study 2285437 — intervention group
Group type: COMPARATOR
Intervention: Control (4 days)
Number of subjects: 131
Study 6813360 — intervention group
Group type: EXPERIMENTAL
Intervention: acebutolol (mean dose 913 mg/day) during single-blind phase
Number of subjects: 25
Study 6813360 — intervention group
Group type: EXPERIMENTAL
Intervention: acebutolol (mean dose 968 mg/day) during double-blind phase
Number of subjects: 25
Study 6813360 — intervention group
Group type: EXPERIMENTAL
Intervention: acebutolol during single-blind phase
Number of subjects: 25
Study 6813360 — intervention group
Group type: COMPARATOR
Intervention: placebo during double-blind phase
Number of subjects: 25
Study 31093649 — intervention group
Group type: EXPERIMENTAL
Intervention: Tenofovir monoester
Number of subjects: 24
Study 31093649 — intervention group
Group type: EXPERIMENTAL
Intervention: Plasma tenofovir
Number of subjects: 24
Study 29261248 — intervention group
Group type: EXPERIMENTAL
Intervention: Social Work Intervention Focused on Transitions (up to 2 in-home visits and up to 4 telephone follow-up calls)
Number of subjects: 90
Study 29261248 — intervention group
Group type: EXPERIMENTAL
Intervention: Opting out of the intervention (refusal of home visit component)
Number of subjects: 90
Study 29261248 — intervention group
Group type: EXPERIMENTAL
Intervention: Opting out of the intervention
Number of subjects: 90
Study 29261248 — intervention group
Group type: EXPERIMENTAL
Intervention: Having a diagnosis of cancer
Number of subjects: 90
Study 26242435 — intervention group
Group type: EXPERIMENTAL
Intervention: Delayed cord clamping (DCC) at 3 minutes after delivery
Number of subjects: 105
Study 26242435 — intervention group
Group type: COMPARATOR
Intervention: Early cord clamping (ECC) at around 1 minute after delivery
Number of subjects: 105
Study 26242435 — intervention group
Group type: EXPERIMENTAL
Intervention: Delayed cord clamping (DCC)
Number of subjects: 105
Study 26242435 — intervention group
Group type: COMPARATOR
Intervention: Early cord clamping (ECC)
Number of subjects: 105
Study 25782323 — intervention group
Group type: COMPARATOR
Intervention: Traditional monitoring (Group 1)
Number of subjects: 168
Study 25782323 — intervention group
Group type: COMPARATOR
Intervention: Rheumatologist visits every 12 weeks (Group 2)
Number of subjects: 168
Study 25782323 — intervention group
Group type: EXPERIMENTAL
Intervention: Telephone counseling once every 4 weeks (Group 3)
Number of subjects: 168
Study 22735077 — intervention group
Group type: EXPERIMENTAL
Intervention: CST training and outreach support
Number of subjects: 0
Study 22735077 — intervention group
Group type: COMPARATOR
Intervention: CST training only
Number of subjects: 0
Study 22735077 — intervention group
Group type: EXPERIMENTAL
Intervention: Monitoring centres running groups in usual practice
Number of subjects: 0
Study 19318471 — intervention group
Group type: EXPERIMENTAL
Intervention: gp100(209‐2M) vaccination
Number of subjects: 0
Study 17462655 — intervention group
Group type: EXPERIMENTAL
Intervention: Plate-mounted marker group
Number of subjects: 10
Study 17462655 — intervention group
Group type: COMPARATOR
Intervention: Strap-mounted marker group
Number of subjects: 10
Study 15698940 — intervention group
Group type: EXPERIMENTAL
Intervention: Calcium 1 g + Vitamin D 800 IU daily
Number of subjects: 30
Study 15698940 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 30
Study 12693587 — intervention group
Group type: EXPERIMENTAL
Intervention: Dihydroartemisinin 240 mg and mefloquine 1,250 mg given over 3 days (Group 1)
Number of subjects: 0
Study 12693587 — intervention group
Group type: COMPARATOR
Intervention: Dihydroartemisinin 240 mg and azithromycin 1,500 mg given over 3 days (Group 2)
Number of subjects: 0
Study 9714943 — intervention group
Group type: EXPERIMENTAL
Intervention: Cognitive behavioral multidisciplinary pain management program
Number of subjects: 0
Study 7982362 — intervention group
Group type: EXPERIMENTAL
Intervention: Intervention group mothers (enhanced maternal sensitive responsiveness)
Number of subjects: 2
Study 7982362 — intervention group
Group type: EXPERIMENTAL
Intervention: Intervention infants
Number of subjects: 2
Study 7982362 — intervention group
Group type: EXPERIMENTAL
Intervention: Intervention group dyads
Number of subjects: 2
Study 7982362 — intervention group
Group type: COMPARATOR
Intervention: Control group mothers
Number of subjects: 2
Study 7982362 — intervention group
Group type: COMPARATOR
Intervention: Control infants
Number of subjects: 2
Study 7982362 — intervention group
Group type: COMPARATOR
Intervention: Control group dyads
Number of subjects: 2
Study 2920667 — intervention group
Group type: EXPERIMENTAL
Intervention: Alcohol (0.8 ml of pure alcohol/kg body weight)
Number of subjects: 24
Study 2920667 — intervention group
Group type: COMPARATOR
Intervention: Control group
Number of subjects: 24
Study 4555651 — intervention group
Group type: EXPERIMENTAL
Intervention: Heparin
Number of subjects: 48
Study 4555651 — intervention group
Group type: COMPARATOR
Intervention: Control (no heparin)
Number of subjects: 48
Study 29303777 — intervention group
Group type: EXPERIMENTAL
Intervention: Laser acupuncture (12 sessions, 90 mw, 1 min per acupoint, total energy 5.4 joules per acupoint, 21.6 joules to ashi points, wavelength 808 nm)
Number of subjects: 40
Study 29303777 — intervention group
Group type: COMPARATOR
Intervention: Sham laser (laser probe directed to acupoints while the device is off)
Number of subjects: 40
Study 27590788 — intervention group
Group type: EXPERIMENTAL
Intervention: Multiple periods of outdoor free play (3 periods of at least 15 minutes each)
Number of subjects: 14
Study 27590788 — intervention group
Group type: COMPARATOR
Intervention: Single period of outdoor play (control group)
Number of subjects: 14
Study 24839884 — intervention group
Group type: EXPERIMENTAL
Intervention: 1.3 grams of omega-3 fatty acids daily for 6 weeks
Number of subjects: 57
Study 24839884 — intervention group
Group type: COMPARATOR
Intervention: Identical placebo daily for 6 weeks
Number of subjects: 57
Study 23514054 — intervention group
Group type: EXPERIMENTAL
Intervention: Laparoscopic peptic ulcer repair (LR)
Number of subjects: 115
Study 23514054 — intervention group
Group type: COMPARATOR
Intervention: Open peptic ulcer repair (OR)
Number of subjects: 115
Study 19648905 — intervention group
Group type: EXPERIMENTAL
Intervention: SICS
Number of subjects: 160
Study 19648905 — intervention group
Group type: COMPARATOR
Intervention: CECS
Number of subjects: 160
Study 17457340 — intervention group
Group type: EXPERIMENTAL
Intervention: Plant-based dietary portfolio (high in plant sterols 1.0 g/1000 kcal, soy protein 22.5 g/1000 kcal, viscous fibers 10 g/1000 kcal, almonds 22.5 g/1000 kcal)
Number of subjects: 66
Study 16837543 — intervention group
Group type: EXPERIMENTAL
Intervention: Trabeculotomy ab externo
Number of subjects: 8
Study 16837543 — intervention group
Group type: EXPERIMENTAL
Intervention: Viscocanalostomy
Number of subjects: 8
Study 16837543 — intervention group
Group type: COMPARATOR
Intervention: Both interventions
Number of subjects: 8
Study 12940842 — intervention group
Group type: EXPERIMENTAL
Intervention: Three or more modifiable vascular risk factors
Number of subjects: 500
Study 12940842 — intervention group
Group type: EXPERIMENTAL
Intervention: Asymptomatic carotid stenosis (ACS) of 50% or greater
Number of subjects: 500
Study 12940842 — intervention group
Group type: EXPERIMENTAL
Intervention: Modifiable vascular risk factors
Number of subjects: 500
Study 12940842 — intervention group
Group type: EXPERIMENTAL
Intervention: Hypertension and cardiac diseases
Number of subjects: 500
Study 12940842 — intervention group
Group type: EXPERIMENTAL
Intervention: Cardiac diseases and obesity
Number of subjects: 500
Study 12940842 — intervention group
Group type: EXPERIMENTAL
Intervention: ACS and high low-density lipoprotein (LDL) cholesterol levels
Number of subjects: 500
Study 10679756 — intervention group
Group type: EXPERIMENTAL
Intervention: 3-month neoadjuvant LH-RH-analogue treatment
Number of subjects: 103
Study 10679756 — intervention group
Group type: COMPARATOR
Intervention: Surgery alone (control group)
Number of subjects: 103
Study 9275141 — intervention group
Group type: EXPERIMENTAL
Intervention: Aqueous wheat flour extract inhalation at concentrations of 0.01, 0.1, 1, 10, and 100 mg/ml for 10 minutes.
Number of subjects: 36
Study 9275141 — intervention group
Group type: EXPERIMENTAL
Intervention: Wheat flour dust inhalation from Spinhaler capsules (1, 2, or 4 capsules, maximum of 7 cumulative capsules).
Number of subjects: 36
Study 9275141 — intervention group
Group type: COMPARATOR
Intervention: Control group (atopic subjects) inhaling wheat flour dust from capsules.
Number of subjects: 36
Study 9275141 — intervention group
Group type: EXPERIMENTAL
Intervention: Both methods (aqueous extract and dust inhalation).
Number of subjects: 36
Study 9275141 — intervention group
Group type: EXPERIMENTAL
Intervention: Only subjects with a positive skin test response to wheat flour.
Number of subjects: 36
Study 8148487 — intervention group
Group type: EXPERIMENTAL
Intervention: Tamoxifen (89 patients, treated group)
Number of subjects: 149
Study 8148487 — intervention group
Group type: COMPARATOR
Intervention: Control (60 patients, controls)
Number of subjects: 149
Study 8148487 — intervention group
Group type: EXPERIMENTAL
Intervention: Current users of tamoxifen (n = 18)
Number of subjects: 149
Study 8148487 — intervention group
Group type: EXPERIMENTAL
Intervention: Ex-users of tamoxifen (n = 71)
Number of subjects: 149
Study 3094919 — intervention group
Group type: EXPERIMENTAL
Intervention: Epidural morphine (Group E)
Number of subjects: 13
Study 3094919 — intervention group
Group type: COMPARATOR
Intervention: Intravenous morphine (Group I)
Number of subjects: 13
Study 2568211 — intervention group
Group type: EXPERIMENTAL
Intervention: Dexmedetomidine 12.5 micrograms
Number of subjects: 5
Study 2568211 — intervention group
Group type: EXPERIMENTAL
Intervention: Dexmedetomidine 25 micrograms
Number of subjects: 5
Study 2568211 — intervention group
Group type: EXPERIMENTAL
Intervention: Dexmedetomidine 50 micrograms
Number of subjects: 5
Study 2568211 — intervention group
Group type: EXPERIMENTAL
Intervention: Dexmedetomidine 75 micrograms
Number of subjects: 5
Study 2568211 — intervention group
Group type: EXPERIMENTAL
Intervention: Dexmedetomidine (all doses)
Number of subjects: 5
Study 31722820 — intervention group
Group type: EXPERIMENTAL
Intervention: Midazolam (buccal, intranasal or intramuscular)
Number of subjects: 0
Study 31722820 — intervention group
Group type: EXPERIMENTAL
Intervention: Lorazepam or Diazepam (IV agents)
Number of subjects: 0
Study 31722820 — intervention group
Group type: EXPERIMENTAL
Intervention: Levetiracetam
Number of subjects: 0
Study 31722820 — intervention group
Group type: EXPERIMENTAL
Intervention: Valproate
Number of subjects: 0
Study 31722820 — intervention group
Group type: EXPERIMENTAL
Intervention: Phenytoin (and its prodrug fosphenytoin)
Number of subjects: 0
Study 31722820 — intervention group
Group type: EXPERIMENTAL
Intervention: Phenobarbitone
Number of subjects: 0
Study 31722820 — intervention group
Group type: EXPERIMENTAL
Intervention: Benzodiazepines
Number of subjects: 0
Study 30293408 — intervention group
Group type: EXPERIMENTAL
Intervention: Intermittent hypoxic resistance training (IHRT)
Number of subjects: 25
Study 30293408 — intervention group
Group type: COMPARATOR
Intervention: Normoxia (FIO2=21%)
Number of subjects: 25
Study 27436368 — intervention group
Group type: EXPERIMENTAL
Intervention: Hemostatic suture
Number of subjects: 90
Study 27436368 — intervention group
Group type: COMPARATOR
Intervention: Bipolar electrocoagulation
Number of subjects: 90
Study 25465924 — intervention group
Group type: EXPERIMENTAL
Intervention: MGuard stent
Number of subjects: 433
Study 25465924 — intervention group
Group type: COMPARATOR
Intervention: Control stent
Number of subjects: 433
Study 22545977 — intervention group
Group type: EXPERIMENTAL
Intervention: Cognitive-behavioral stress management (CBSM) group
Number of subjects: 65
Study 22545977 — intervention group
Group type: COMPARATOR
Intervention: Psychoeducational seminar
Number of subjects: 65
Study 20924913 — intervention group
Group type: EXPERIMENTAL
Intervention: Computer training program for memory improvement
Number of subjects: 30
Study 20924913 — intervention group
Group type: COMPARATOR
Intervention: Standard group treatment
Number of subjects: 30
Study 19536890 — intervention group
Group type: EXPERIMENTAL
Intervention: sipuleucel-T
Number of subjects: 225
Study 16614150 — intervention group
Group type: EXPERIMENTAL
Intervention: Rofecoxib
Number of subjects: 50
Study 16614150 — intervention group
Group type: COMPARATOR
Intervention: Ibuprofen
Number of subjects: 50
Study 16614150 — intervention group
Group type: EXPERIMENTAL
Intervention: Embolosphere Gold
Number of subjects: 50
Study 16614150 — intervention group
Group type: EXPERIMENTAL
Intervention: Contour SE
Number of subjects: 50
Study 12093941 — intervention group
Group type: EXPERIMENTAL
Intervention: Tonsillectomy
Number of subjects: 328
Study 12093941 — intervention group
Group type: EXPERIMENTAL
Intervention: Adenotonsillectomy
Number of subjects: 328
Study 12093941 — intervention group
Group type: COMPARATOR
Intervention: Control
Number of subjects: 328
Study 12093941 — intervention group
Group type: EXPERIMENTAL
Intervention: Surgery (both tonsillectomy and adenotonsillectomy)
Number of subjects: 328
Study 10748773 — intervention group
Group type: EXPERIMENTAL
Intervention: Irrigation suction drainage (ISD) with 6000 ml of saline solution per day for 7 or more days
Number of subjects: 105
Study 10748773 — intervention group
Group type: COMPARATOR
Intervention: Irrigation suction drainage (ISD) with 2000 ml of saline solution per day
Number of subjects: 105
Study 10748773 — intervention group
Group type: EXPERIMENTAL
Intervention: Irrigation suction drainage (ISD) with 6000 ml of saline solution per day
Number of subjects: 105
Study 10748773 — intervention group
Group type: EXPERIMENTAL
Intervention: Irrigation suction drainage (ISD)
Number of subjects: 105
Study 7723966 — intervention group
Group type: EXPERIMENTAL
Intervention: Stereotactic ventral pallidotomy
Number of subjects: 18
Study 7723966 — intervention group
Group type: COMPARATOR
Intervention: Control group (nonsurgically treated)
Number of subjects: 18
Study 1915807 — intervention group
Group type: EXPERIMENTAL
Intervention: alpha interferon
Number of subjects: 108
Study 1915807 — intervention group
Group type: EXPERIMENTAL
Intervention: monthly 5 day courses with thioguanine and cytarabine
Number of subjects: 108
Study 1915807 — intervention group
Group type: COMPARATOR
Intervention: nothing (control)
Number of subjects: 108
Study 7250173 — intervention group
Group type: EXPERIMENTAL
Intervention: Ibopamine hydrochloride (SB 7505) at doses starting from 100 mg to 350 mg
Number of subjects: 12
Study 7250173 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 12
Study 7250173 — intervention group
Group type: EXPERIMENTAL
Intervention: Ibopamine hydrochloride (SB 7505)
Number of subjects: 12
Study 31020400 — intervention group
Group type: EXPERIMENTAL
Intervention: Pole Walking (PW)
Number of subjects: 14
Study 31020400 — intervention group
Group type: COMPARATOR
Intervention: Walking (W)
Number of subjects: 14
Study 28351163 — intervention group
Group type: EXPERIMENTAL
Intervention: Desloratadine 5 mg/d
Number of subjects: 30
Study 28351163 — intervention group
Group type: COMPARATOR
Intervention: Control group (not treated)
Number of subjects: 30
Study 26521223 — intervention group
Group type: EXPERIMENTAL
Intervention: Group physical activity and diet educational program
Number of subjects: 332
Study 26521223 — intervention group
Group type: COMPARATOR
Intervention: Control group (no intervention)
Number of subjects: 332
Study 23815891 — intervention group
Group type: EXPERIMENTAL
Intervention: Clinical decision support system (intervention group A)
Number of subjects: 0
Study 23815891 — intervention group
Group type: EXPERIMENTAL
Intervention: Clinical decision support system (intervention group B)
Number of subjects: 0
Study 23815891 — intervention group
Group type: COMPARATOR
Intervention: Control group
Number of subjects: 0
Study 21944133 — intervention group
Group type: EXPERIMENTAL
Intervention: Tamsulosin (various doses)
Number of subjects: 161
Study 21944133 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 161
Study 21944133 — intervention group
Group type: EXPERIMENTAL
Intervention: Tamsulosin (low dose)
Number of subjects: 161
Study 21944133 — intervention group
Group type: EXPERIMENTAL
Intervention: Tamsulosin (medium dose)
Number of subjects: 161
Study 21944133 — intervention group
Group type: EXPERIMENTAL
Intervention: Tamsulosin (high dose)
Number of subjects: 161
Study 21944133 — intervention group
Group type: EXPERIMENTAL
Intervention: Tamsulosin
Number of subjects: 161
Study 21944133 — intervention group
Group type: COMPARATOR
Intervention: Tamsulosin and Placebo
Number of subjects: 161
Study 18272935 — intervention group
Group type: EXPERIMENTAL
Intervention: Exercise (EX)
Number of subjects: 74
Study 18272935 — intervention group
Group type: COMPARATOR
Intervention: Control (CON)
Number of subjects: 74
Study 16691043 — intervention group
Group type: EXPERIMENTAL
Intervention: Yakson therapy
Number of subjects: 29
Study 16691043 — intervention group
Group type: COMPARATOR
Intervention: GHT therapy
Number of subjects: 29
Study 12928048 — intervention group
Group type: EXPERIMENTAL
Intervention: Alzheimer's disease patients
Number of subjects: 25
Study 12928048 — intervention group
Group type: COMPARATOR
Intervention: Control subjects
Number of subjects: 25
Study 12928048 — intervention group
Group type: EXPERIMENTAL
Intervention: Combined patient and control groups
Number of subjects: 25
Study 17536290 — intervention group
Group type: EXPERIMENTAL
Intervention: Intermittent Pulsatile Compression (IPC)
Number of subjects: 20
Study 17536290 — intervention group
Group type: COMPARATOR
Intervention: Slow Sequential Compression (SCD)
Number of subjects: 20
Study 8629747 — intervention group
Group type: EXPERIMENTAL
Intervention: IV ketamine (0.2 mg/kg bolus followed by 0.5 mg/kg/hour infusion for 3 hours, adjusted to 0.1 mg/kg bolus for the first 9 patients)
Number of subjects: 53
Study 8629747 — intervention group
Group type: COMPARATOR
Intervention: Placebo (bolus and infusion for 3 hours)
Number of subjects: 53
Study 8629747 — intervention group
Group type: EXPERIMENTAL
Intervention: IV ketamine
Number of subjects: 53
Study 8629747 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 53
Study 8629747 — intervention group
Group type: COMPARATOR
Intervention: IV ketamine and Placebo
Number of subjects: 53
Study 1310465 — intervention group
Group type: EXPERIMENTAL
Intervention: Isoflurane
Number of subjects: 20
Study 1310465 — intervention group
Group type: COMPARATOR
Intervention: Halothane
Number of subjects: 20
Study 6658721 — intervention group
Group type: EXPERIMENTAL
Intervention: Verapamil 120 mg given perorally three times a day for three months
Number of subjects: 52
Study 6658721 — intervention group
Group type: COMPARATOR
Intervention: Control group (not specified)
Number of subjects: 52
Study 31795283 — intervention group
Group type: EXPERIMENTAL
Intervention: Cinnamate esters
Number of subjects: 0
Study 31795283 — intervention group
Group type: EXPERIMENTAL
Intervention: QSAR modeling
Number of subjects: 0
Study 31795283 — intervention group
Group type: EXPERIMENTAL
Intervention: Molecular descriptors analysis
Number of subjects: 0
Study 29730198 — intervention group
Group type: EXPERIMENTAL
Intervention: Deferred radical prostatectomy
Number of subjects: 132
Study 25263242 — intervention group
Group type: EXPERIMENTAL
Intervention: HSS 3% with epinephrine (3 mL)
Number of subjects: 64
Study 25263242 — intervention group
Group type: COMPARATOR
Intervention: HSS 3% with placebo (3 mL)
Number of subjects: 64